Wockhardt Limited (WOCKPHARMA.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-99.7%

₹5.19

vs ₹1,900.50 price

Levered DCF

-₹108.89

After debt service

Piotroski score

5 / 9

Average

Altman Z-score

—

Rating

C-

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	89.61×	-482.63×	-18.65×	-3.97×	-13.02×	-15.32×	-10.76×	-16.02×
P/B	3.86×	5.18×	2.57×	0.66×	0.83×	1.36×	0.66×	1.73×
P/S	5.66×	7.42×	3.05×	0.83×	0.98×	1.69×	0.62×	1.3×
EV / EBITDA	31.08×	58.01×	51.92×	39.92×	16.8×	-115.16×	51.6×	-690.59×
Gross margin	38.2%	60.2%	56.5%	55.9%	58.2%	55.3%	55.4%	51.9%
Operating margin	11.9%	34.7%	29.5%	26.6%	30.6%	19.7%	21.0%	18.6%
Net margin	6.3%	-1.5%	-16.4%	-21.0%	-7.6%	25.3%	-2.4%	-5.5%
Current ratio	1.61×	1.21×	0.78×	0.64×	0.81×	0.78×	0.69×	0.98×
Debt / equity	0.45×	0.46×	0.7×	0.65×	0.57×	0.79×	1.34×	1.26×
Interest coverage	1.89×	4.15×	2.74×	2.34×	3.3×	2.14×	2.17×	2.51×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	-0.8%	0.1%	0.0%	-0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	4.3%	-1.1%	-13.8%	-16.7%	-6.3%	20.3%	-2.6%	-7.3%
Return on invested capital	4.4%	15.5%	13.3%	11.7%	10.1%	4.2%	3.6%	7.2%
Return on assets	2.5%	-0.6%	-6.1%	-7.3%	-3.0%	8.8%	-0.8%	-2.5%
Free cash flow yield	0.3%	-0.5%	0.0%	-2.5%	6.3%	-9.9%	27.1%	-2.0%
Earnings yield	1.1%	-0.2%	-5.4%	-25.2%	-7.7%	15.0%	-3.9%	-4.2%
Enterprise value	₹210.7B	₹243.6B	₹104.9B	₹43.1B	₹50.1B	₹70.2B	₹51.2B	₹76.2B
Net debt / EBITDA	2.92×	4.36×	9.16×	19.39×	6.13×	-40.01×	33.86×	-269.92×
Cash conversion cycle (days)	120	120	43	44	68	155	102	128